Patents by Inventor Tobias Schlueter

Tobias Schlueter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Crystalline forms of 1-(4-{[6-amino-5-(4-phenoxy-phenyl)-pyrimidin-4-ylamino]-methyl}-4-fluoro-piperidin-1-yl)-propenone, salt forms thereof, and processes to obtain
    Patent number: 11878967
    Abstract: A solid form of 1-(4-{[6-Amino-5-(4-phenoxy-phenyl)-pyrimidin-4-ylamino]-methy}-4-fluoro-piperidin-1-yl)-propenone, or pharmaceutically acceptable salts thereof, is useful as a BTK inhibitor.
    Type: Grant
    Filed: June 17, 2019
    Date of Patent: January 23, 2024
    Assignee: Merck Patent GmbH
    Inventors: Michael Lange, Clemens Kuehn, Tobias Schlueter, Werner Mederski, David Maillard, Edoardo Burini
  • CABLE SCREW-CONNECTION SYSTEM
    Publication number: 20220399704
    Abstract: A cable gland system for arrangement on a housing wall includes: a guide element with an opening for receiving a cable, a first support surface for supporting on a first side of the housing wall and a first end region, and an opposite second end region, at least one external thread being arranged at least on a periphery of the first end region; and a fastening element with a second support surface for supporting on a second side of the housing wall, and an internal thread on an inner surface, the internal thread engaging with the external thread on the guide element in a screwed-on state. At least one contact surface with a contact structure respectively arranged on the periphery of the guide element, adjacent to the external thread and to the inner surface of the fastening element.
    Type: Application
    Filed: November 16, 2020
    Publication date: December 15, 2022
    Inventors: Tobias Schlueter, Antje Skowranek
  • NOVEL CRYSTALLINE FORMS OF 1-(4-{[6-AMINO-5-(4-PHENOXY-PHENYL)-PYRIMIDIN-4-YLAMINO]-METHYL}-4-FLUORO-PIPERIDIN-1-YL)-PROPENONE, SALT FORMS THEREOF, AND PROCESSES TO OBTAIN
    Publication number: 20210261525
    Abstract: A solid form of 1-(4-{[6-Amino-5-(4-phenoxy-phenyl)-pyrimidin-4-ylamino]-methy}-4-fluoro-piperidin-1-yl)-propenone, or pharmaceutically acceptable salts thereof, is useful as a BTK inhibitor.
    Type: Application
    Filed: June 17, 2019
    Publication date: August 26, 2021
    Applicant: Merck Patent GmbH
    Inventors: Michael LANGE, Clemens Kuehn, Tobias Schlueter, Werner Mederski, David Maillard, Edoardo Burini
  • Polymorphic forms and process
    Patent number: 8198452
    Abstract: The invention relates to a process for the manufacture of enantiomerically enriched or pure compounds of formula I wherein R1, R2, R3, R6, R7 and Q are defined as in claim 1 as well as their crystalline forms for the treatment of proliferative diseases such as cancer.
    Type: Grant
    Filed: May 26, 2007
    Date of Patent: June 12, 2012
    Assignee: Merck Patent Gesellschaft MIT Beschränkter Haftung
    Inventors: Kai Schiemann, Ulrich Emde, Tobias Schlueter, Christoph Saal, Michael Maiwald
  • POLYMORPHIC FORMS AND PROCESS
    Publication number: 20090176820
    Abstract: The invention relates to a process for the manufacture of enantiomerically enriched or pure compounds of formula I wherein R1, R2, R3, R6, R7 and Q are defined as in claim 1 as well as their crystalline forms for the treatment of proliferative diseases such as cancer.
    Type: Application
    Filed: May 26, 2007
    Publication date: July 9, 2009
    Inventors: Kai Schiemann, Ulrich Emde, Tobias Schlueter, Christoph Saal, Michael Maiwald